0000899243-21-018112.txt : 20210504 0000899243-21-018112.hdr.sgml : 20210504 20210504163119 ACCESSION NUMBER: 0000899243-21-018112 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201208 FILED AS OF DATE: 20210504 DATE AS OF CHANGE: 20210504 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Seidel-Dugan Cynthia CENTRAL INDEX KEY: 0001857799 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40366 FILM NUMBER: 21889018 MAIL ADDRESS: STREET 1: 1030 MASSACHUSETTS AVENUE STREET 2: SUITE 210 CITY: CAMBRIDGE STATE: MA ZIP: 02138 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Werewolf Therapeutics, Inc. CENTRAL INDEX KEY: 0001785530 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 823523180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1030 MASSACHUSETTS AVENUE STREET 2: SUITE 210 CITY: CAMBRIDGE STATE: MA ZIP: 02138 BUSINESS PHONE: 617-952-0555 MAIL ADDRESS: STREET 1: 1030 MASSACHUSETTS AVENUE STREET 2: SUITE 210 CITY: CAMBRIDGE STATE: MA ZIP: 02138 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-08 0 0001785530 Werewolf Therapeutics, Inc. HOWL 0001857799 Seidel-Dugan Cynthia C/O WEREWOLF THERAPEUTICS, INC. 1030 MASSACHUSETTS AVENUE, SUITE 210 CAMBRIDGE MA 02138 0 1 0 0 Chief Scientific Officer Stock Option (right to buy) 4.77 2020-12-08 4 A 0 99163 0.00 A 2030-12-07 Common Stock 99163 99163 D Stock Option (right to buy) 16.00 2021-04-30 4 A 0 57908 0.00 A 2031-04-29 Common Stock 57908 57908 D The option was granted on December 8, 2020. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the grant date and 2.0833% of the shares vesting each month thereafter through December 8, 2024. The option was granted on April 30, 2021. The shares underlying the option vest over four years in equal monthly installments through April 30, 2025. /s/ Reid Leonard, Attorney-in-fact 2021-05-04